Article
Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells
2 Jun 2022
Abstract excerpt
Carboplatin is the most used first-line drug for the treatment of human retinoblastoma (RB), a rare form of cancer in infancy and childhood. However, the clinical application of carboplatin is restricted due to the emergence of acquired multi-drug resistance (MDR) after long-term treatment. Here, we report a new strategy to eliminate MDR RB cells by inducing autophagy-dependent ferroptosis. Compared with parent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
